<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="161623">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02133495</url>
  </required_header>
  <id_info>
    <org_study_id>KMBella1</org_study_id>
    <nct_id>NCT02133495</nct_id>
  </id_info>
  <brief_title>An Outcomes Assessment of the Utility of Belladerm Acellular Dermal Allograft in Ocular Lower Lid Retraction Repair</brief_title>
  <official_title>Use of Non-Cadaveric Human Acellular Dermal Tissue (BellaDermÂ®) in Lower Eyelid Retraction Repair</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>SGM Physician Research Consortium</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Musculoskeletal Transplant Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>SGM Physician Research Consortium</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to Evaluate the efficacy and longevity of a Human-derived,
      non-cadaveric, acellular dermal implant (BellaDerm) as a posterior spacer graft in the
      correction of lower eyelid retraction, taking into consideration issues associated with the
      use of acelular dermis such as contraction and potential regression of repairs.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To Evaluate the efficacy and longevity of a Human-derived, non-cadaveric, acellular dermal
      implant (BellaDerm) as a posterior spacer graft in the correction of lower eyelid
      retraction, taking into consideration issues associated with the use of acelular dermis such
      as contraction and potential regression of repairs.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2011</start_date>
  <completion_date type="Actual">January 2014</completion_date>
  <primary_completion_date type="Actual">January 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Pre and Post operative margin reflex distance 2 MRD 2</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>Pre and postoperative margin reflex distance 2 (MRD2) and inferior scleral show (ISS) was measured of each eyelid, and success was defined as a positive eyelid elevation and decrease in inferior scleral show. Long- term stability beyond 12 months was evaluated.</description>
  </primary_outcome>
  <other_outcome>
    <measure>Inferior scleral show</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>Pre and post operative margin reflex distance 2 (MRD2) and inferior scleral show (ISS) where measured for each eyelid elevation and decrease in inferior scleral show.</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">12</enrollment>
  <condition>Lower Eyelid Retraction</condition>
  <arm_group>
    <arm_group_label>open label</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Non Cadaveric human BellaDerm Acellular dermal tissue</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Non Cadaveric Human Acellular Dermal Tissue</intervention_name>
    <arm_group_label>open label</arm_group_label>
    <other_name>Bella Derm</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Lower eyelid retraction, defined as inferior displacement of the lower eyelid margin
             with inferior scleral show, may be asymptomatic

          -  May have ocular irritation including foreign body sensation, burning, photophobia and
             tearing.

          -  May have aesthetically unsatisfactory eyelid appearance.

        Exclusion Criteria:

          -  Have a condition that would be contraindicated to surgery
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>95 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Morgenstern Center for Orbital and Facial Plastic Surgery</name>
      <address>
        <city>Wayne</city>
        <state>Pennsylvania</state>
        <zip>19087</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 7, 2014</lastchanged_date>
  <firstreceived_date>May 6, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>SGM Physician Research Consortium</investigator_affiliation>
    <investigator_full_name>Kenneth Morgenstern, MD</investigator_full_name>
    <investigator_title>Kenneth Morgenstern, MD</investigator_title>
  </responsible_party>
  <keyword>lower eyelid</keyword>
  <keyword>retraction</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
